FI955238A - Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents

Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset Download PDF

Info

Publication number
FI955238A
FI955238A FI955238A FI955238A FI955238A FI 955238 A FI955238 A FI 955238A FI 955238 A FI955238 A FI 955238A FI 955238 A FI955238 A FI 955238A FI 955238 A FI955238 A FI 955238A
Authority
FI
Finland
Prior art keywords
aryloxymethyl
oxazolines
alkyl
new
compounds
Prior art date
Application number
FI955238A
Other languages
English (en)
Swedish (sv)
Other versions
FI955238A0 (fi
Inventor
Christian Jarry
Isabelle Forfar
Jean-Jacques Bosc
Pierre Renard
Elizabeth Scalbert
Beatrice Guardiola
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI955238A0 publication Critical patent/FI955238A0/fi
Publication of FI955238A publication Critical patent/FI955238A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI955238A 1994-11-03 1995-11-01 Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset FI955238A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413087A FR2726558B1 (fr) 1994-11-03 1994-11-03 Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FI955238A0 FI955238A0 (fi) 1995-11-01
FI955238A true FI955238A (fi) 1996-05-04

Family

ID=9468429

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955238A FI955238A (fi) 1994-11-03 1995-11-01 Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Country Status (16)

Country Link
US (1) US5686477A (fi)
EP (1) EP0710658B1 (fi)
JP (1) JP3181211B2 (fi)
CN (1) CN1051545C (fi)
AT (1) ATE206414T1 (fi)
AU (1) AU689320B2 (fi)
CA (1) CA2162106C (fi)
DE (1) DE69523011T2 (fi)
DK (1) DK0710658T3 (fi)
ES (1) ES2165410T3 (fi)
FI (1) FI955238A (fi)
FR (1) FR2726558B1 (fi)
NO (1) NO305755B1 (fi)
NZ (1) NZ280387A (fi)
PT (1) PT710658E (fi)
ZA (1) ZA959311B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635668B1 (en) * 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
BR0206491A (pt) * 2001-01-16 2004-07-06 Eastman Chem Co Concentrado para colorir um poliéster base, composição de poliéster, artigo moldado, e, métodos para preparar uma composição de poliéster colorida, e para colorir uma composição de poliéster
BR0212078A (pt) * 2001-08-31 2004-09-28 Neurochem Int Ltd Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
MX2009008465A (es) * 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2016105449A1 (en) * 2014-12-22 2016-06-30 Seth Lederman Compounds for use as pain therapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052688A (en) * 1962-09-04 Process for the production of
US3110650A (en) * 1961-09-14 1963-11-12 Szabo Hnos Kessler & Cia S R L Synergistic analgesic compositions
US3278382A (en) * 1962-07-23 1966-10-11 Mcneilab Inc 2-amino-5-aryloxazoline compositions and methods of using same
US3161650A (en) * 1963-01-25 1964-12-15 Mcneilab Inc 2-amino-5-aryloxazoline products
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3577428A (en) * 1969-04-14 1971-05-04 Colgate Palmolive Co 2-amino-4-aryloxyalkyl-4-alkyl-2-oxazolines
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3818028A (en) * 1972-11-01 1974-06-18 Dow Chemical Co Substituted-5-(2,4,6-trihalophenoxy)-methyl)-2-oxazoline compounds
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
FR2645860B1 (fr) * 1989-04-14 1991-07-26 Sarget Lab Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques

Also Published As

Publication number Publication date
NZ280387A (en) 1996-07-26
CA2162106A1 (fr) 1996-05-04
AU3459395A (en) 1996-05-09
ZA959311B (en) 1996-05-29
US5686477A (en) 1997-11-11
EP0710658A1 (fr) 1996-05-08
PT710658E (pt) 2002-02-28
ATE206414T1 (de) 2001-10-15
JPH08208630A (ja) 1996-08-13
DK0710658T3 (da) 2001-11-26
NO954381D0 (no) 1995-11-02
FI955238A0 (fi) 1995-11-01
CN1129697A (zh) 1996-08-28
DE69523011T2 (de) 2002-07-11
CN1051545C (zh) 2000-04-19
DE69523011D1 (de) 2001-11-08
AU689320B2 (en) 1998-03-26
NO305755B1 (no) 1999-07-19
FR2726558A1 (fr) 1996-05-10
NO954381L (no) 1996-05-06
JP3181211B2 (ja) 2001-07-03
FR2726558B1 (fr) 1996-12-06
CA2162106C (fr) 2001-04-10
EP0710658B1 (fr) 2001-10-04
ES2165410T3 (es) 2002-03-16

Similar Documents

Publication Publication Date Title
BR9703447A (pt) Novos compostos 3-(piperid-4-il)-1,2-benzisoxazol e 3-(piperazin-4-il) 1,2-benzisoxazol processos para a preparação dos mesmos e composições farmacêuticas contendo os mesmo
DK234388A (da) 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling
ES521125A0 (es) Procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas.
FI955238A (fi) Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI933719A0 (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
NO996284L (no) Nye imidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
NO996285D0 (no) Nye spiroimidazolinforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO972942D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
HUP0203835A2 (en) Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient
HUT65376A (en) Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
HUP9903074A2 (hu) 2-(3H)-Oxazolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
HF Priority information amended